Company Email Format Management

Vivoryon Therapeutics N.V.

Biotechnology Research Halle Saale, De 20 employees

Employees: 20
Contacts: 4
Emails: 3
Phones: 2

probiodrug.de LinkedIn

Vivoryon Therapeutics N.V. Overview

Headquarters: Halle Saale, De
Website: probiodrug.de
Industry: Biotechnology Research
Employees: 20
Founded: 1997
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

About Vivoryon Therapeutics N.V.

Vivoryon is a clinical stage biotechnology company focused on developing innovative small molecule-based medicines for the treatment of inflammatory and fibrotic disorders of the kidney. Driven by its passion for ground-breaking science and innovation, the Company strives to improve patient outcomes by changing the course of severe diseases through modulating the activity and stability of pathologically relevant proteins. Vivoryon’s most advanced program, varoglutamstat, a proprietary, first-in-class orally available QPCT/L inhibitor, is being evaluated to treat diabetic kidney disease.

Vivoryon Therapeutics N.V. Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Vivoryon Therapeutics N.V. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Samir Shah	Public Affairs & Policy, Asia Pacific	Singapore	Email
Anne Doering		Frankfurt Rhine-main Metropolitan Area, Germany	Phone
Claudia Riedl (Aka Gutjahr-löser)	Senior Advisor at Mc Services Ag	Bavaria, Germany	Email Phone
Stefan Tasler	Pcc Tasler - Preclinical Consulting	Greater Munich Metropolitan Area, Germany	Email